Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Asahi Kasei A Bpep"

23:44 EDT 31st July 2014 | BioPortfolio

Matching Channels


Matching News

Asahi Kasei Corporation: Company Profile and SWOT Analysis

Recently added to the BioPortfolio report store, Asahi Kasei Corporation: Company Profile and SWOT Analysis is a new report from ICD Research published on 2011-09-09. This 35-page report is availabl...

RaQualia and Asahi Kasei Pharma progress their collaboration

RaQualia Pharma says that its ongoing joint research with fellow Japanese drugmaker Asahi Kasei Pharma has moved to a new phase. Following the positive results from the collaborative research under th...

US Court upholds damages award in Actelion/Asahi litigation

Switzerland-based Actelion says that the California Supreme Court has denied the firm’ petition for review of the Court of Appeal's decision affirming the final judgment entered against Actelion in...

Actelion, Asahi Kasei Pharma, Washington Legal Foundation cardiovascular news

Zoll Receives Shonin Approval from Japanese Ministry of Health, Labour and Welfare to Market the R Series Monitor/Defibrillator

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that its Japanese subsidiary, Asahi Kasei ZOLL Medical (AZM), has recei...

CoAxia sells all of its assets to Zoll Medical

Emergency care device manufacturer Zoll Medical Corp., bought last year for $1.2bn by Japanese diversified company Asahi Kasei Corp., has acquired all of the assets of privately held CoAxia Inc. (inst...

Roughly 90% Of Large Japanese Companies Extend Care Leave: Asahi Survey

With the turnover of nursing and care employees being 100,000 per year in Japan, roughly 90% of large companies in the country are extending nursing leave to a period longer than that required by law,...

Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan

CHESTERBROOK, Pa., July 31, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that the Company will receive a $10 million regul...

Matching PubMed Articles

Intravitreal fasudil combined with bevacizumab for treatment of refractory diabetic macular edema; a pilot study.

To evaluate the effect of intravitreal injection of a Rho-associated protein kinase (ROCK) inhibitor (Fasudil, Asahi Kasei Pharma Corporation, Tokyo, Japan) combined with intravitreal bevacizumab (IVB...

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement